|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,195.00 JPY | +0.45% |
|
-0.67% | +26.06% |
| 01/05 | US FDA approves Axsome's drug for Alzheimer's-related agitation | RE |
| 28/04 | Otsuka Holdings' Profit Rises 16% in Q1 | MT |
| Capitalization | 5,868B 37.17B 31.75B 29.09B 27.5B 50.92B 3,558B 51.18B 346B 135B 1,688B 139B 137B | P/E ratio 2026 * |
19.1x | P/E ratio 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise value | 5,380B 34.08B 29.1B 26.67B 25.21B 46.68B 3,262B 46.92B 318B 124B 1,548B 128B 125B | EV / Sales 2026 * |
2.09x | EV / Sales 2027 * | 1.97x |
| Free-Float |
81.6% | Yield 2026 * |
1.31% | Yield 2027 * | 1.4% |
Last Transcript: Otsuka Holdings Co., Ltd.
| 1 day | +0.36% | ||
| 1 week | -0.67% | ||
| Current month | -1.89% | ||
| 1 month | +6.68% | ||
| 3 months | +5.67% | ||
| 6 months | +36.44% | ||
| Current year | +26.06% |
| 1 week | 10,725 | 11,545 | |
| 1 month | 10,390 | 11,550 | |
| Current year | 8,671 | 11,610 | |
| 1 year | 6,465 | 11,610 | |
| 3 years | 4,799 | 11,610 | |
| 5 years | 3,827 | 11,610 | |
| 10 years | 3,224 | 11,610 |
| Manager | Title | Age | Since |
|---|---|---|---|
Makoto Inoue
CEO | Chief Executive Officer | 67 | 01/01/2025 |
Yuko Makino
DFI | Director of Finance/CFO | 64 | 01/03/2018 |
Masanori Udagawa
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Tatsuo Higuchi
BRD | Director/Board Member | 75 | 08/07/2008 |
Noriko Tojo
BRD | Director/Board Member | 62 | 20/08/2008 |
Yoshiro Matsuo
BRD | Director/Board Member | 65 | 08/07/2008 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.45% | -0.67% | +63.40% | +129.34% | 36.68B | ||
| -1.13% | +0.22% | +8.22% | +90.88% | 46.27B | ||
| +2.73% | -0.46% | -12.17% | +41.62% | 10.91B | ||
| +0.92% | +2.96% | +6.15% | +82.88% | 9.78B | ||
| +1.22% | +2.05% | +39.11% | +119.38% | 8.99B | ||
| +0.08% | -3.58% | +16.79% | +49.07% | 7.39B | ||
| -1.18% | +6.67% | +62.77% | -2.18% | 7.38B | ||
| -2.96% | -26.59% | -2.33% | +8.63% | 6.37B | ||
| +0.91% | -5.80% | +64.84% | +271.58% | 6.65B | ||
| -3.86% | -2.56% | +192.52% | +544.59% | 6.46B | ||
| Average | -0.31% | -2.93% | +43.93% | +133.58% | 14.69B | |
| Weighted average by Cap. | -0.25% | -1.33% | +35.63% | +115.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2,576B 16.32B 13.93B 12.77B 12.07B 22.35B 1,562B 22.47B 152B 59.18B 741B 61.22B 59.94B | 2,646B 16.76B 14.31B 13.11B 12.4B 22.96B 1,604B 23.08B 156B 60.79B 761B 62.89B 61.57B |
| Net income | 306B 1.94B 1.66B 1.52B 1.43B 2.66B 186B 2.67B 18.06B 7.03B 88.04B 7.27B 7.12B | 327B 2.07B 1.77B 1.62B 1.53B 2.84B 198B 2.85B 19.31B 7.52B 94.11B 7.77B 7.61B |
| Net Debt | -488B -3.09B -2.64B -2.42B -2.29B -4.24B -296B -4.26B -28.82B -11.22B -140B -11.6B -11.36B | -655B -4.15B -3.54B -3.24B -3.07B -5.68B -397B -5.71B -38.63B -15.04B -188B -15.56B -15.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/05/26 | 11,195.00 ¥ | +0.45% | 105,500 |
| 13/05/26 | 11,145.00 ¥ | +1.41% | 785,100 |
| 12/05/26 | 10,990.00 ¥ | 0.00% | 667,100 |
| 11/05/26 | 10,990.00 ¥ | -0.32% | 1,032,500 |
| 08/05/26 | 11,025.00 ¥ | -2.09% | 1,554,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4578 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















